GlobeNewswire

Regen BioPharma, Inc. Provides Shareholder Update on Company’s Activities and Direction
05/11/2026
SAN DIEGO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) Update on Regen’s recent activities (i.e.: debt payoff, financing, potential joint ventures): The Company has recently paid off [...]
GenomOncology Integrates ARUP Laboratories’ Jalapheno Phenotype-Matching Tool Into GO Pathology Workbench Under Multiyear Exclusive Agreement
05/11/2026
Gene-level phenotype-matching scores from patient Human Phenotype Ontology (HPO) terms now feed directly into variant prioritization for rare disease exome, genome, and large-panel germline testing, alongside new [...]
Rectify Pharmaceuticals Presents Translational Data on RTY-406 at AASLD 2026 Liver Meeting
05/11/2026
Presentation highlights preclinical characterization of RTY-406, an oral, once-daily investigational therapy targeting underlying drivers of hepatobiliary diseases BOSTON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rectify [...]
Madrigal Announces New Real-World Data at AASLD 2026 Demonstrating Improvements in Liver Stiffness and Cardiometabolic Health Markers with Rezdiffra
05/11/2026
In real-world studies, up to 93% of patients experienced improvement or stabilization in liver stiffness with ultrasound elastography, with many patients moving into lower liver stiffness categories one year after [...]
Altimmune Announces Data from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder Selected as Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2026
05/11/2026
First presentation at a scientific conference of key data from RECLAIM, a multicenter Phase 2 trial of a balanced 1:1 glucagon/GLP-1 receptor agonist in alcohol use disorder (AUD) Presentation to take place on Monday, [...]
Resolution Therapeutics Announces Positive Interim Phase I/II EMERALD Data for Regenerative Macrophage Therapy RTX001 in End-Stage Liver Disease
05/11/2026
Six-month interim data showed a 42% relative risk reduction in death, liver transplant or hepatic decompensation versus an external control RTX001 was well tolerated with no infusion-related serious adverse reactions; [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
05/11/2026
Bagsværd, Denmark. 5 November 2026 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
KFSH Riyadh Earns Davos Healthcare’s Global Elite Five-Star Medallion, Ranking Among Top 5% of Evaluated Hospitals
05/11/2026
RIYADH, Saudi Arabia, Nov. 05, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) in Riyadh has received Davos Healthcare’s Global Elite Five-Star Medallion, the highest distinction in [...]
Former Ministers and a Former Head of Government Press the G20 to Put Brain Health Inside Its AI Agenda
05/11/2026
Global Communiqué urges prevention as the foundation of Alzheimer’s policy, and a standing G20 mechanism so leadership on brain health outlasts individual governments WASHINGTON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Former [...]
Every like and share supports care for Saskatchewan kids
05/11/2026
Before you scroll past, consider this: your click could bring life-saving equipment to kids in Saskatchewan. SASKATOON, Saskatchewan, Nov. 05, 2026 (GLOBE NEWSWIRE) -- This November, Saskatchewan Blue Cross is once [...]
Compounded Semaglutide Cost per Month Stays the Same From 0.25 mg to 2.4 mg at NexLife
05/11/2026
Standard compounded semaglutide injections prescribed through NexLife are $119 a month on the 12-month plan or $139 month to month at every weekly dose from 0.25 mg to 2.4 mg; standard compounded tirzepatide injections [...]
Kraig Labs Advances Commercial Spider Silk Production with New Customer Shipments and New Silkworm Research
05/11/2026
DENVER, Nov. 05, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews )— Kraig Biocraft Laboratories (OTCQB: KBLB) recently shipped its first commercial order of recombinant spider silk yarn to a globally recognized sportswear [...]
Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results
05/11/2026
Press Release – No. 22 / 2026 Zealand Pharma conference call on Nov 12 at 2pm CET (8am ET) to present third quarter 2026 financial results Copenhagen, Denmark, November 5, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR- [...]
Genmab Announces Financial Results for the Nine Months of 2026
05/11/2026
November 5, 2026 Copenhagen, Denmark; Interim Report for the Nine Months Ended September 30, 2026 Highlights Epcoritamab approved in Europe (as TEPKINLY ® ) and Japan (as EPKINLY ® ) in combination with R² for the [...]
Osteal Therapeutics Announces Three Scientific Presentations Related to the APEX Clinical Trial Program at the 2026 AAHKS Annual Meeting
05/11/2026
Presentations will address 24-month treatment outcomes, systemic antibiotic exposure, and new treatment strategies for recalcitrant periprosthetic joint infection DALLAS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Osteal [...]
Dyne Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
05/11/2026
- Biologics License Application (BLA) for z-rostudirsen in exon 51 Duchenne muscular dystrophy (DMD) under priority review by FDA; PDUFA target action date of January 21, 2027 - - Additional one-year clinical data from [...]
Cronos Group Reports 2026 Third Quarter Results
05/11/2026
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q3 20 26 increased by 73% year-over-year on an organic, constant-currency basis Generated record net [...]
Medicus Pharma to Present at BIO-Europe 2026
05/11/2026
Medicus Chief Medical Officer will Highlight Company’s Focus on Precision Oncology, Anchored by CD228V targeted ADC and Partner Ready Therapeutic Programs PHILADELPHIA, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma [...]
Collegium Reports Third Quarter 2026 Financial Results; Reaffirms 2026 Guidance
05/11/2026
– Generated Record Quarterly Net Revenues of $216.3 Million, Up 3% Year-over-Year – – Generated Record JORNAY PM ® Quarterly Net Revenue of $51.9 Million, Up 24% Year-over-Year – – Generated AZSTARYS ® Quarterly Net [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum